Triptolide induces s phase arrest and apoptosis in gallbladder cancer cells

Yun-Ping Hu1, Zhu-Jun Tan1, Xiang-Song Wu1

  • 1Institute of Biliary Tract Disease, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University, School of Medicine, No. 1665 Kongjiang Road, Shanghai 200092, China.

Insights

Triptolide effectively inhibits gallbladder cancer cell growth and survival. This natural compound induces cell cycle arrest and apoptosis, suggesting its potential as a novel gallbladder carcinoma treatment.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Gallbladder carcinoma has a poor prognosis and limited treatment options.
  • New therapeutic strategies are urgently needed for this malignancy.

Purpose of the Study:

  • To investigate the anticancer effects of triptolide on gallbladder cancer cells.
  • To elucidate the underlying mechanisms of triptolide's action.

Main Methods:

  • MTT assay for cell viability.
  • Colony formation assay for cell proliferation.
  • Flow cytometry for cell cycle analysis and apoptosis.
  • Western blot for apoptosis-related protein expression.

Main Results:

  • Triptolide reduced gallbladder cancer cell viability and colony formation.
  • Triptolide induced S phase arrest and apoptosis.
  • Triptolide decreased mitochondrial membrane potential and modulated apoptosis-related proteins (caspase-3, caspase-9, PARP, Bcl-2).

Conclusions:

  • Triptolide exhibits significant anticancer activity against gallbladder cancer cells.
  • Triptolide induces apoptosis through the regulation of key proteins.
  • Triptolide shows promise as a potential therapeutic agent for gallbladder carcinoma.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.2K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K